Communicable disease threats report, 29 September-5 October 2019, week 40
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 September-5 October 2019 and includes updates on Ebola virus disease, extensively drug-resistant Klebsiella pneumoniae, mass gathering monitoring (Japan, Rugby World Cup 2019), Middle East respiratory syndrome coronavirus, Plasmodium cynomolgi infection, poliomyelitis, West Nile virus, and yellow fever.
Response plan to control and manage the threat of multi- and extensively drug-resistant gonorrhoea in Europe
ECDC reviewed the response plan and the 2019 update strives to further support EU Member States to develop and implement national strategies and interventions to control the threat of multidrug-resistant and extensively drug-resistant gonorrhoea in a multidisciplinary approach by outlining the suggested public health response to this threat with several vital components.
Open call for journalists to attend EAAD
ECDC is inviting a limited number of journalists to attend the EU-level launch event marking the 12th European Antibiotic Awareness Day. ECDC will cover travelling and accommodation expenses for the successful applicants.
Country visit to Estonia to discuss policies relating to antimicrobial resistance
The European Centre for Disease Prevention and Control (ECDC) and the European Commission's Directorate General for Health and Food Safety jointly carried out this country visit to Estonia from 25 to 29 March 2019. The visit was carried out following the invitation from the competent authorities to assist them in the preparation of their national strategy for tackling antimicrobial resistance (AMR) based on a 'One Health' perspective.
European Antibiotic Awareness Day 2019: Launch event
The event is a platform for governmental institutions, professional and patient organisations, country representatives and media to come together and discuss the current situation regarding antibiotic resistance and the actions taken to address them by all stakeholders, both at EU/EEA and national levels.
Euro-GASP external quality assessment scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing
External quality assessment (EQA) is an essential part of any laboratory-based surveillance system, allowing for the monitoring of performance and comparability of results from participating laboratories, identification of potential issues, and deployment of resources and training where necessary.
Privacy Statement - Processing of personal data for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
Data are processed for the conduct of the carbapenem- and/or colistin-resistant Enterobacteriaceae (CCRE) survey as part of molecular surveillance of antimicrobial resistant pathogens according to a protocol. For the CCRE survey bacterial isolates (carbapenem and/or colistin-resistant Enterobacteriaceae and susceptible control isolates) and related patient data are collected in hospitals in 37 countries with the aim to determine transmission pathways and improve control measures.
Training course on control of multidrug-resistant micro-organisms in health care settings
ECDC is organising a short course on “Control of multidrug-resistant micro-organisms (MDROs) in health care settings”. This training opportunity is addressed at healthcare professionals from European Union (EU) and European Economic Area (EEA) countries with current or future responsibility for the prevention and control of healthcare-associated infections (HAIs) due to MDROs working at national or local level. The course is offered by invitation only and participants are identified through the ECDC Coordinating Competent Bodies.
Rapid risk assessment: Regional outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacteriaceae, Italy, 2018–2019
A large outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacteriaceae (CRE) has been reported from the Tuscany region in Italy. Between November 2018 and May 2019, seven Tuscan hospitals notified a total of 350 cases.